QuidelOrtho Corp — Investor Relations & Filings
Filings indexed
398
across all filing types
Latest filing
2026-04-27
Annual Report
Country
US
United States of America
Listing
US
QDEL
QuidelOrtho Corp is a global developer and manufacturer of in vitro diagnostic products. The company provides a broad range of testing solutions that span the healthcare continuum, from clinical laboratories and hospitals to at-home consumer use. Its portfolio encompasses technologies in immunoassay, molecular diagnostics, clinical chemistry, and immunohematology. These products are designed to deliver fast, accurate, and reliable results for the detection and management of various health conditions, including infectious diseases such as COVID-19, influenza, HIV, and hepatitis C. QuidelOrtho focuses on transforming diagnostic data into actionable insights to improve patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - QuidelOrtho Corp (0001906324) (Filer) | 2026-04-27 | English | |
| 8-K - QuidelOrtho Corp (0001906324) (Filer) | 2026-03-24 | English | |
| 10-K - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-19 | English | |
| 8-K - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-13 | English | |
| 4 - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-13 | English | |
| 4 Filing | 2026-02-13 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 37617026 | ARS - QuidelOrtho Corp (0001906324) (Filer) | 2026-04-27 | English | ||
| 33026638 | 8-K - QuidelOrtho Corp (0001906324) (Filer) | 2026-03-24 | English | ||
| 32900448 | 10-K - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-19 | English | ||
| 32900446 | 8-K - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-13 | English | ||
| 32900443 | 4 - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-13 | English | ||
| 32201382 | 4 Filing | 2026-02-13 | English | ||
| 32201366 | 4 Filing | 2026-02-13 | English | ||
| 32201335 | 8-K Filing | 2026-02-11 | English | ||
| 32900444 | 4 - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-10 | English | ||
| 32900445 | 4 - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-10 | English | ||
| 32900447 | 8-K - QUIDELORTHO CORP (0001906324) (Filer) | 2026-02-05 | English | ||
| 32201333 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 32201442 | 4 Filing | 2026-02-03 | English | ||
| 32201404 | 4 Filing | 2026-02-03 | English | ||
| 32201395 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
QuidelOrtho Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31696/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31696 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31696 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31696 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31696}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for QuidelOrtho Corp (id: 31696)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.